Fingerprint
Dive into the research topics of 'Subcutaneous IGF-1 is not beneficial in 2-year als trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Subcutaneous IGF-1 is not beneficial in 2-year als trial
Charles L. Howe, Rachel A. Bergstrom, Bruce F. Horazdovsky
Research output: Contribution to journal › Letter › peer-review
15
Scopus
citations